Shandong Suncadia Medicine Co., Ltd.

This study followed 81 obese participants who had already completed a previous trial of HRS-7535 weight loss tablets. Researchers tracked them for an additional 32 weeks to check long-term safety and see if weight loss benefits continued. The study measured side effects, weight c…

This study tested whether two different oral medications could help people with chronic kidney disease. Researchers enrolled 181 adults who were already on standard blood pressure medications. They measured how well the drugs reduced protein in urine and protected kidney function…

This study tested whether a new oral medication called HRS-5346 could safely lower levels of lipoprotein(a), a fatty particle in the blood linked to heart attack and stroke risk. It involved 120 adults who already had heart disease or were at high risk for it and had high lipopro…

This study tested whether the investigational drug HRS-7535 can help protect the kidneys in adults with type 2 diabetes who have early to moderate diabetic kidney disease. For 16 weeks, 281 participants received either HRS-7535 or a placebo (inactive pill) to see if the drug safe…

This study tested whether a new oral medication called HRS-7535 could help adults with type 2 diabetes who still had high blood sugar despite taking two common diabetes drugs (metformin and an SGLT2 inhibitor). For 16 weeks, 155 participants received either the new drug or a plac…

This early-stage study aimed to check the safety and basic effects of a new pain medication called HRS-2129. It involved 23 healthy adults who received the drug and underwent tests to see how it changed their sensitivity to hot and cold pain. The main goal was to see if the drug …

This early study tested how a common antifungal drug (itraconazole) affects the way the body processes a new experimental breast cancer drug (HRS-8080). Researchers gave both drugs to 16 healthy volunteers to measure drug levels in the blood and check for safety. The goal is to u…

This is a first-in-human study to check the safety and how the body processes a new drug called HRS-1301. It enrolled 82 healthy adults to receive single or multiple doses. The main goal is to see what side effects occur and how long the drug stays in the blood and urine.

This study looked at how HRS-1893, an experimental tablet for hypertrophic cardiomyopathy, behaves in people with different levels of kidney function. Researchers compared drug levels in 24 participants—some with mild to moderate kidney problems and some with healthy kidneys—to u…

This was a small, early-stage study to see how a new drug called HRS-1301 affects the way the body processes a common cholesterol-lowering medicine (rosuvastatin). It involved 16 healthy adults to measure drug levels in the blood and check for safety. The main goal was to gather …

This study looked at how a potential new diabetes medication, HRS-7535, is processed by the body and how safe it is in people with mild to moderate liver problems compared to people with normal liver function. It involved 24 adults to measure the drug's levels in the blood and ch…